Tirzepatide
Dual receptor GLP-1/GIP research peptide for metabolic studies. 10mg vial, 99%+ purity, third party tested.
About This Product
Tirzepatide is a dual action research peptide that targets both GLP-1 and GIP receptors simultaneously. This dual mechanism has made it one of the most extensively studied compounds in metabolic research, with multiple large scale clinical trials demonstrating its effects on body composition and glucose metabolism. Each vial contains 10mg of lyophilized Tirzepatide at 99%+ purity, verified by third party testing. Certificate of Analysis available for download above. Store lyophilized at -20°C for up to 24 months. Once reconstituted with bacteriostatic water, store at 2 to 8°C and use within 30 days.
Compound Information
What Is Tirzepatide?
| Type | Synthetic Peptide |
| Targets | GLP-1, GIP receptors |
| Molecular Weight | 4,813.45 Da |
| Amino Acids | 39 |
| Classification | Dual agonist |
| Purity | 99%+ |
Stability Information
Sources & References
Peer-reviewed research
⚠ Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
